McIlrath & Eck LLC Lowers Position in Procter & Gamble Company (The) $PG

Key Points

• McIlrath & Eck LLC reduced its holdings in Procter & Gamble by 24.6%, owning 5,025 shares valued at $856,000 after selling 1,637 shares in Q1.
• Insider trading was noted as CFO Andre Schulten sold 11,638 shares and another insider, Marc S. Pritchard, sold 9,849 shares, both on August 19, with a significant decrease in their positions.
• Procter & Gamble announced a quarterly dividend of $1.0568 per share, resulting in an annualized yield of 2.7% for investors of record as of July 18.

McIlrath & Eck LLC lowered its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 24.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,025 shares of the company's stock after selling 1,637 shares during the period. McIlrath & Eck LLC's holdings in Procter & Gamble were worth $856,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Northern Trust Corp raised its holdings in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock valued at $5,051,930,000 after acquiring an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock valued at $2,966,252,000 after acquiring an additional 583,629 shares in the last quarter. Royal Bank of Canada raised its holdings in shares of Procter & Gamble by 0.6% in the 1st quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock valued at $2,943,779,000 after acquiring an additional 111,162 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Procter & Gamble by 1.2% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 17,090,898 shares of the company's stock valued at $2,911,989,000 after acquiring an additional 208,991 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the sale, the chief financial officer owned 52,642 shares in the company, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Marc S. Pritchard sold 9,849 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,548,952.23. Following the completion of the sale, the insider owned 182,422 shares of the company's stock, valued at approximately $28,689,507.94. This trade represents a 5.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 over the last quarter. Company insiders own 0.18% of the company's stock.

Procter & Gamble Price Performance

PG opened at $159.12 on Tuesday. The stock's 50 day simple moving average is $156.41 and its 200 day simple moving average is $162.14. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The firm has a market cap of $372.42 billion, a price-to-earnings ratio of 24.44, a PEG ratio of 4.22 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same period last year, the company earned $1.40 EPS. Procter & Gamble's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 64.82%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on PG. BNP Paribas reiterated an "outperform" rating and set a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $170.00 price objective (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Barclays set a $164.00 price objective on Procter & Gamble and gave the company an "equal weight" rating in a research report on Thursday, July 31st. UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. Finally, Wells Fargo & Company reduced their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, Procter & Gamble has a consensus rating of "Moderate Buy" and an average target price of $175.12.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.